Shailubhai, Kunwar
Synergy Pharmaceuticals (United States)
4 papers on CoChat
Most cited papers
- Verified
A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation
Miner, P. B., Koltun, W. D., Wiener, G. J., De La Portilla, M., Prieto, B., Shailubhai, K., Layton, M. B., Barrow, L., Magnus, L., & Griffin, P. H. (2017) · American Journal of Gastroenterology
Gastrointestinal motility and disordersPelvic floor disorders treatments
Cited by 141
- Verified
Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod
Choudhari, S. R., Khan, M. A., Harris, G., Picker, D., Jacob, G. S., Block, T., & Shailubhai, K. (2007) · Molecular Cancer Therapeutics
Cytokine Signaling Pathways and InteractionsHepatocellular Carcinoma Treatment and Prognosis
Cited by 90
- Verified
Randomized clinical trial: Efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation
DeMicco, M., Barrow, L., Hickey, B., Shailubhai, K., & Griffin, P. (2017) · Therapeutic Advances in Gastroenterology
Gastrointestinal motility and disordersPelvic floor disorders treatments
Cited by 74
- Verified
967 Plecanatide, like uroguanylin, activates guanylate Cyclase-C signaling in a pH-dependent manner in T84 cells, and in murine intestinal epithelial cells and tissues
Patwa, V., Joshi, A., Thadi, A., Eddy, E. P., Palejwala, V. A., Jacob, G. S., & Shailubhai, K. (2016) · Gastroenterology
Gastrointestinal motility and disordersNeuropeptides and Animal Physiology
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free